Press Release: Univest Securities, LLC Announces Closing of $6.9 Million Initial Public Offering for its Client AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C (NASDAQ: AHMA)
New York, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of an initial public offering (the “Offering”) of 1,725,000 class A ordinary shares, par value US$0.0000001 per share (the “Class…
PANAMA CITY, Oct. 25, 2025 (GLOBE NEWSWIRE) -- The crypto market is buzzing as Blazpay’s Phase 2 Crypto Presale continues its rapid ascent, now 76% complete with over $843.6K raised. Priced at $0.0075 per BLAZ token, Blazpay’s Next Big Crypto Coin offers an unmatched early-entry opportunity before the next phase increases the price to $0.009375. This…
NEW YORK, Oct. 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of KBR, Inc. (NYSE: KBR) between May 6, 2025 and June 19, 2025, both dates inclusive (the “Class Period”), of the important November 18, 2025 lead plaintiff deadline in the securities class action…
DFY Vending Logo BOCA RATON, Fla., Oct. 25, 2025 (GLOBE NEWSWIRE) -- DFY Vending, a leading U.S.-based provider of Done-For-You vending machine solutions, announced today the nationwide expansion of its popular Vending Machines program, bringing a turnkey passive income opportunity to more investors than ever before. This milestone reflects DFY Vending’s continued commitment to offering…
– 100% responspercentage in 1L linkszijdige mCRC (n=8, bevestigd en onbevestigd) – 62% responspercentage in 2L links- en rechtszijdige mCRC (n=13, bevestigd en onbevestigd) UTRECHT, Nederland en CAMBRIDGE, Massachusetts, Oct. 25, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, het Bedrijf, wij of ons/onze), een oncologiebedrijf dat innovatieve, multispecifieke full-length antilichamen en antilichaam-geneesmiddelconjugaten (Biclonics®, Triclonics® en…
Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data from its Phase 3 COMPETE trial in patients with Grade 1 or Grade 2 somatostatin receptor (SSTR)-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Results showed consistently higher objective response rates (ORR) and longer progression-free survival (PFS) across…
Thu, 04 Sep 2025 05:00:00 GMT NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- StoneX Commodity Solutions (SCS), a subsidiary of StoneX Group Inc. (NASDAQ: SNEX) ("StoneX"), announced today the completion of its acquisition of Right ...
